RYMDF Relay Medical Corp.

Relay Medical Corp. operates as a medical technology company, which engages in the development of novel medical devices for in vitro diagnostics and point-of-care testing. Its platform technologies include HemoPalm, Pharmatrac, and Osprey. The HemoPalm develops a POCT unit-use cartridge based blood analyzer with full enterprise capabilities. The Pharmatrac is an AI and data analytics driven personal medication management system that addresses the growing problem of non-adherence to treatment. The Osprey, commercializes products and services related to the management of decentralized fleets of medical devices and the data streams they produce. The company was founded by James Samsoondar in 2005 and is headquartered in Toronto, Canada.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$0.12    OTCQB
As of 01/25/2022     OTCMarkets

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Unknown
Industry:  Diagnostics & Research
Index country:  Canada
Country of incorporation:  
IPO date:  03/05/2007
Outstanding shares:  0
Average volume:  15,018
Market cap:   $38,404,056
Current dividend yield:  0.00%
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   1.61
PS ratio:   447.16
Return on equity:   -98.84%
Net income %:   -17,723.11%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy